Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites

J Neurochem. 1998 Oct;71(4):1535-43. doi: 10.1046/j.1471-4159.1998.71041535.x.

Abstract

Mutations in the presenilin genes PS1 and PS2 cause the most common form of early-onset familial Alzheimer's disease. The influence of PS1 mutations on the generation of endogenous intracellular amyloid beta-protein (A beta) species was assessed using a highly sensitive immunoblotting technique with inducible mouse neuroblastoma (Neuro 2a) cell lines expressing the human wild-type (wt) or mutated PS1 (M146L or delta exon 10). The induction of mutated PS1 increased the intracellular levels of two distinct A beta species ending at residue 42 that were likely to be A beta1-42 and its N-terminally truncated variant(s) A beta x-42. The induction of mutated PS1 resulted in a higher level of intracellular A beta1-42 than of intracellular A beta x-42, whereas extracellular levels of A beta1-42 and A beta x-42 were increased proportionally. In addition, the intracellular generation of these A beta42 species in wt and mutated PS1-induced cells was completely blocked by brefeldin A, whereas it exhibited differential sensitivities to monensin: the increased accumulation of intracellular A beta x-42 versus inhibition of intracellular A beta1-42 generation. These data strongly suggest that A beta x-42 is generated in a proximal Golgi, whereas A beta1-42 is generated in a distal Golgi and/or a post-Golgi compartment. Thus, it appears that PS1 mutations enhance the degree of 42-specific gamma-secretase cleavage that occurs in the normal beta-amyloid precursor protein processing pathway (a) in the endoplasmic reticulum or the early Golgi apparatus prior to beta-secretase cleavage or (b) in the distinct sites where A beta x-42 and A beta1-42 are generated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / biosynthesis*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Brefeldin A
  • Cyclopentanes / pharmacology
  • Extracellular Space / metabolism
  • Gene Expression Regulation / drug effects
  • Genetic Linkage*
  • Humans
  • Intracellular Fluid / metabolism*
  • Macrolides
  • Membrane Proteins / genetics*
  • Membrane Proteins / pharmacology*
  • Mice
  • Monensin / pharmacology
  • Mutation / genetics*
  • Peptide Fragments / biosynthesis*
  • Peptide Fragments / metabolism
  • Presenilin-1
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Amyloid beta-Peptides
  • Anti-Bacterial Agents
  • Cyclopentanes
  • Macrolides
  • Membrane Proteins
  • PSEN1 protein, human
  • Peptide Fragments
  • Presenilin-1
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
  • Brefeldin A
  • Monensin